Cambridge, MA · Founded 2016 · Privately Held (backing)
Developer of genomic tools designed to improve human health and sustainability. Arbor Biotechnologies is based in Cambridge, MA and was founded in 2016. It was valued at $239 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $305 million across 2 recorded rounds; the latest was a $215 million later-stage round in Oct 2021.
PMV mark · valuation
$238.9M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$304.5M
Last round
Later Stage VC
Oct 2021
Cap table — not yet on record
Arbor Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Arbor Biotechnologies with a free account
·The complete investor list: 31 names
·Watch Arbor Biotechnologies: the Monday email on marks, rounds and moves
Where does Arbor Biotechnologies's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Arbor Biotechnologies's 2 recorded funding rounds.
